Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Karyopharm Therapeutics (KPTI) over the last 14 years, with Q4 2025 value amounting to $5.3 million.

  • Karyopharm Therapeutics' Non-Current Assets fell 3376.07% to $5.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.2 million, marking a year-over-year increase of 839.46%. This contributed to the annual value of $5.3 million for FY2025, which is 3376.07% down from last year.
  • Karyopharm Therapeutics' Non-Current Assets amounted to $5.3 million in Q4 2025, which was down 3376.07% from $6.5 million recorded in Q3 2025.
  • Karyopharm Therapeutics' Non-Current Assets' 5-year high stood at $29.7 million during Q4 2021, with a 5-year trough of $4.7 million in Q3 2024.
  • Moreover, its 5-year median value for Non-Current Assets was $7.4 million (2023), whereas its average is $10.0 million.
  • In the last 5 years, Karyopharm Therapeutics' Non-Current Assets crashed by 7898.67% in 2021 and then soared by 3738.61% in 2025.
  • Karyopharm Therapeutics' Non-Current Assets (Quarter) stood at $29.7 million in 2021, then tumbled by 73.03% to $8.0 million in 2022, then fell by 18.64% to $6.5 million in 2023, then rose by 22.08% to $8.0 million in 2024, then tumbled by 33.76% to $5.3 million in 2025.
  • Its Non-Current Assets stands at $5.3 million for Q4 2025, versus $6.5 million for Q3 2025 and $7.0 million for Q2 2025.